Article

Long-Term Efficacy of Sublingual Immunotherapy in Patients With Perennial Rhinitis

Istanbul University, İstanbul, Istanbul, Turkey
The Laryngoscope (Impact Factor: 2.03). 07/2007; 117(6):965-9. DOI: 10.1097/MLG.0b013e31804f8141
Source: PubMed

ABSTRACT Sublingual immunotherapy has a documented clinical efficacy, but only a few long-term studies have been performed in people with perennial rhinitis.
The purpose of this study was to evaluate the long-term efficacy of sublingual immunotherapy.
One hundred thirty-seven patients with allergies to house dust mites were treated with sublingual house dust-mite-specific immunotherapy for 2 or 3 years and were also observed for 3 years after discontinuation of the treatment. The patients were divided into 2 groups: group A (67 patients) received active treatment for 2 years and then 1 year for placebo, and group B (70 patients) received active treatment for 3 years. The success of the treatment was evaluated with the symptom score, skin prick test results, and the nasal allergen challenge score.
According to our study results, we found a greater improvement in the 3 years of sublingual immunotherapy compared with the 2 years of sublingual immunotherapy when we looked at the comparative results of the total 6 years.
We suggest 3 years of sublingual immunotherapy for patients with perennial allergic rhinitis who require immunotherapy and do not accept the subcutaneous route of allergen administration.

0 Followers
 · 
76 Views
  • Source
    Allergy, asthma & immunology research 03/2015; 7(2):99-100. DOI:10.4168/aair.2015.7.2.99 · 3.08 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Given the widespread prevalence of allergic disease, its substantially associated clinical and economic burden, the unique disease-modifying benefits of allergy immunotherapy (AIT), and increased availability of sublingual immunotherapy (SLIT), a critical update of the evidence for AIT-related cost savings [for both subcutaneous immunotherapy (SCIT) and SLIT] is particularly relevant and timely. The present article reviews the evidence for SCIT-related and SLIT-related cost savings derived from a systematic review of the published literature.
    Current Opinion in Allergy and Clinical Immunology 06/2014; DOI:10.1097/ACI.0000000000000084 · 3.66 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Der nasale Provokationstest (NPT) ist ein standardisiertes Verfahren zum Nachweis der klinischen Relevanz einer allergischen Rhinitis. Der NPT ist ein Verfahren mit hoher Spezifität und Sensitivität. Er wird in erster Linie bei unklaren oder widersprüchlichen Vorbefunden zu einer eindeutigen Klärung der vorliegenden Typ-I-Sensibilisierung angewendet. In einzelnen Studien wurde er auch bereits zur Verlaufskontrolle bei der spezifischen Immuntherapie und bei Verdacht auf Analgetikaintoleranz durchgeführt. Die Durchführung des NPT ist einfach und ungefährlich, als nachteilig ist jedoch der hohe Zeitaufwand von etwa 45 Minuten pro Einzeltestung, bei einer titrierten NPT sogar von bis zu drei Stunden, zu sehen. Zur Auswertung stehen neben der subjektiven semiquantitativen Erfassung von Sekretion, Irritation und Fernsymptomen mittels Scores auch etablierte objektivierende Messverfahren wie die aktive anteriore Rhinomanometrie, die akustische und optische Rhinometrie und andere zur Verfügung. Die Durchführung des NPT ist im deutschsprachigen Raum durch eine Leitlinie standardisiert, allerdings sind einige Aspekte wie z. B. die adäquate Applikationsmenge und -technik noch Gegenstand der wissenschaftlichen Diskussion. Summary The nasal provocation test (NPT) is a standardized method for the detecting the clinical relevance of allergic rhinitis. It’s a method of high specificity and sensitivity. The NPT helps identifying a type I sensitization in cases of unclear or contradictory previous diagnostic results and furthermore it appears to be a good tool in monitoring the clinical effect of specific immunotherapy in clinical trials, as well as detecting a possible aspirine-intolerance-syndrome (Samter’s syndrome). The NPT is a very simple, reasonable and safe method on the one hand, but on the other the performance is quite time consuming. A single test takes approximately 45 minutes and a complete titration up to 3 hours. Subjective and semiquantitative methods like secretion, irritation and remote symptoms documented in semiquantitative scores as well as well-established objective methods of measurement such as anterior rhinomanometry, acoustical and optical rhinometry and others are used to evaluate the NPT. In German speaking countries the NPT is standardized by a guideline, only a few aspect such as the adequate dose and technique remain subject of scientific debate.
    Allergo Journal: interdisziplinäre Zeitschrift für Allergologie und Umweltmedizin: Organ der Deutschen Gesellschaft für Allergie- und Immunitätsforschung 04/2013; 22(3):189-202. DOI:10.1007/s15007-013-0090-7